Skip to content
OpenCapital
Get started

Kiniksa Pharmaceuticals International, plc KNSA Other Nonoperating Income

Other Nonoperating Income at other companies

Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$14.98M+68.0%

Other financials

Income statement

See full
Revenue$214.3M+55.5%
Gross profit$193.5M+61.3%
Operating income$29.3M+121%
Net income$22.6M+165%
EPS (diluted)$0.27+145%

Balance sheet

See full
Cash & equivalents$190.0M+20.9%
Total debt$9.0M-9.0%
Total equity$605.7M+32.4%
Total assets$825.3M+37.7%

Cash flow

See full
Operating cash flow$50.2M+125%
CapEx$161.0K+62.6%
Free cash flow$50.0M+125%

Valuation

See full
Market cap$4.58B+128%

Profitability

See full
Gross margin89.3%+3.5pp
Operating margin12.4%+10.2pp
Net margin9.7%+7.6pp
FCF margin21.8%+12.2pp

Returns & leverage

See full
Return on equity13.7%+11.3pp
Debt / equity0×0.0×
Current ratio3.8×+0.1×

Where this comes from

Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncome.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's other nonoperating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's other nonoperating income?
Kiniksa Pharmaceuticals International, plc (KNSA) reported other nonoperating income of $3.41M in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's other nonoperating income changed year-over-year?
Kiniksa Pharmaceuticals International, plc's other nonoperating income increased by 48.9% year-over-year, from $2.29M to $3.41M.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's other nonoperating income?
Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's other nonoperating income has grown at a 231.0% compound annual growth rate (CAGR), from $97K to $11.65M.
What does other nonoperating income mean?
Includes income generated from activities outside the company's core business operations, such as interest income, gains from asset sales, or foreign exchange adjustments. This metric highlights secondary revenue streams that contribute to the bottom line but are not derived from primary product sales. Investors analyze this to understand the impact of non-core financial activities on overall profitability.